Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, PR China.
J Ethnopharmacol. 2022 Nov 15;298:115656. doi: 10.1016/j.jep.2022.115656. Epub 2022 Aug 27.
Alzheimer's disease (AD) is a multicausal neurodegenerative disease clinically characterized by generalized dementia. The pathogenic process of AD not only is progressive and complex but also involves multiple factors and mechanisms, including β-amyloid (Aβ) aggregation, tau protein hyperphosphorylation, oxidative stress, and neuroinflammation. As the first-line treatment for AD, cholinesterase inhibitors can, to a certain extent, relieve AD symptoms and delay AD progression. Nonetheless, the current treatment strategies for AD are far from meeting clinical expectations, and more options for AD treatment should be applied in clinical practice.
The aim of this review was to investigate published reports of C. tinctorius L. and its active constituents in AD treatment through a literature review.
Information was retrieved from scientific databases including Web of Science, ScienceDirect, Scopus, Google Scholar, Chemical Abstracts Services and books, PubMed, dissertations and technical reports. Keywords used for the search engines were "Honghua" or "Carthamus tinctorius L." or "safflower" in conjunction with "(native weeds OR alien invasive)"AND "Chinese herbal medicine".
A total of 47 literatures about C. tinctorius L. and its active constituents in AD treatment through signaling pathways, immune cells, and disease-related mediators and systematically elucidates potential mechanisms from the point of anti-Aβ aggregation, suppressing tau protein hyperphosphorylation, increasing cholinergic neurotransmitters levels, inhibiting oxidative stress, anti-neuroinflammation, ameliorating synaptic plasticity, and anti-apoptosis.
Chinese herbal medicine (CHM) is a treasure endowed by nature to mankind. Emerging studies have confirmed that CHM and its active constituents play a positive role in AD treatment. Carthamus tinctorius L., the most commonly used CHM, can be used with medicine and food, with the effect of activating blood circulation and eliminating blood stasis. In the paper, we have concluded that the existing therapeutic mechanisms of C. tinctorius L. and summarized the potential mechanisms of C. tinctorius L. and its active constituents in AD treatment through a literature review.
阿尔茨海默病(AD)是一种多病因的神经退行性疾病,临床上表现为全面性痴呆。AD 的发病过程不仅是进行性和复杂性的,而且还涉及多个因素和机制,包括β-淀粉样蛋白(Aβ)聚集、tau 蛋白过度磷酸化、氧化应激和神经炎症。作为 AD 的一线治疗方法,胆碱酯酶抑制剂可以在一定程度上缓解 AD 症状并延缓 AD 的进展。然而,目前 AD 的治疗策略远不能满足临床预期,应该在临床实践中应用更多的 AD 治疗选择。
本综述的目的是通过文献回顾调查红花及其活性成分在 AD 治疗中的研究报告。
从科学数据库(包括 Web of Science、ScienceDirect、Scopus、Google Scholar、Chemical Abstracts Services 和书籍、PubMed、论文和技术报告)中检索信息。用于搜索引擎的关键词是“红花”或“红花”或“红花”与“(本地杂草或外来入侵物种)”以及“中草药”结合使用。
共检索到 47 篇关于红花及其活性成分在 AD 治疗中的研究报告,通过信号通路、免疫细胞和疾病相关介质系统地阐明了潜在的机制,从抗 Aβ 聚集、抑制 tau 蛋白过度磷酸化、增加胆碱能神经递质水平、抑制氧化应激、抗神经炎症、改善突触可塑性和抗细胞凋亡等方面。
中草药(CHM)是大自然赋予人类的瑰宝。新兴研究证实,CHM 及其活性成分在 AD 治疗中发挥积极作用。红花是最常用的 CHM 之一,可药用可食用,具有活血化瘀的功效。在本文中,我们总结了红花的现有治疗机制,并通过文献回顾总结了红花及其活性成分在 AD 治疗中的潜在机制。